Effect of Ultrasound Guided Embryo Transfer on Pregnancy Rates

To assess the effect of transabdominal ultrasound guided embryo transfer on the pregnancy rates versus clinical touch technique

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Infertility Genital Diseases Urogenital Diseases

Age range

20 year–39 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

IVF Unit, Ain Shams Maternity Hospital, Ain Shams University

Cairo, Egypt

About this study

A total of 90 patients undergoing treatment with ICSI were divided into 2 groups: group 1 (45 patients), had ultrasound guided embryo transfer and group 2 (45 patients), underwent embryo transfer using the clinical touch technique

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age (20-39)
Male factor infertility
Ovarian factor infertility
Unexplained infertility

Exclusion criteria

Tubal factor infertility
Endometriosis
FSH > 16 iu/l on cycle day 3
Less than 2 embryos grade A
Difficult embryo transfer

Treatment and study plan

GnRh, HMG, HCG, Progesterone

Drug

GnRh analogue (0.05 mg/day), HMG (150-300 iu/day), HCG (5000 iu/day), Progesterone (100 mg/day)

Primary outcomes

To assess clinical pregnancy rates after using ultrasound guided embryo transfer

Time frame: After December, 2012

Sponsors and collaborators

Lead sponsor

Ain Shams Maternity Hospital

Other

Registry information

Acronym: ET

Important dates

Study start: 2009
Primary completion: 2011
Study completion: 2011
First posted: Mar 13, 2013
Registry last updated: Mar 26, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed